Understanding social and health needs of people with chronic liver disease in outpatient care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational project will enroll 200 adult patients with chronic liver disease seen in outpatient liver clinics at Indiana University Health and their visit providers. Patients will complete surveys on demographics, health-related social needs (HRSNs), health literacy, quality of life, social support, and patient activation, with clinical details obtained from chart review. Visit providers will complete surveys about their experiences using HRSN information and their preferences for incorporating it into care. The combined patient- and provider-reported data will describe the prevalence and types of HRSNs, patient preferences for assistance, and provider perspectives on integrating HRSN screening into routine liver care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient Inclusion criteria

  * Age 18 or greater
  * English speaking
  * Ability to give consent (West Haven stage 0-1 if history of hepatic encephalopathy)

Provider Inclusion Criteria • Participated in patient care during inclusion visit

Exclusion Criteria:

* Patient Exclusion criteria

  * History of liver transplant
  * Individuals not willing to participate in the survey
  * Patients with severe cognitive impairment

Provider Exclusion Criteria

• Unable to complete survey within 7 days of the inclusion visit

Where it's running

• Indiana University School of Medicine
  Indianapolis, Indiana, United States Recruiting

Study contacts

• Study coordinator: Savannah Yarnelle
• Email: samussel@iu.edu
• Phone: 3172786424

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing 2-dose and 3-dose hepatitis B vaccine regimens in cirrhosis patients

  This study is testing whether giving two or three doses of the hepatitis B vaccine works better for people with cirrhosis who need protection against the virus.

  Recruiting Phase 4 Mercy Medical Center · Baltimore, Maryland · NCT04588077

• Copper supplementation for people with cirrhosis

  This trial will try giving copper supplements to adults with cirrhosis who have low copper levels or signs of copper deficiency to see if liver-related health improves.

  Recruiting University of Washington · Seattle, Washington · NCT07471542

• Bile acid and gut microbiota changes in people with hepatitis D starting bulevirtide

  This project will see if starting bulevirtide changes bile acids and gut bacteria in adults with chronic hepatitis D who are already on hepatitis B therapy.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07429864

• Diagnosing lymphohistiocytic hemophagocytosis in intensive care patients with liver disease

  This study will test whether the HScore can accurately detect lymphohistiocytic hemophagocytosis in adults with hepatocellular insufficiency or cirrhosis admitted to intensive care.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07343037

• Echocardiography-guided intensive care for septic shock in people with cirrhosis

  This study will try using bedside ultrasound (POCUS) to guide fluid and blood-pressure treatment in adults with cirrhosis who develop sepsis-related low blood pressure.

  Recruiting Post Graduate Institute of Medical Education and Research, Chandigarh · Chandigarh · NCT07286643

• Understanding how chronic liver disease patients with organ failure fare after non‑emergency hospital stays

  This study follows adults with chronic liver disease who are admitted to the hospital non-electively to see how their condition develops over six months when liver and/or other organs fail.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07270809

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.